Gain Therapeutics, Inc. (NASDAQ:GANX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Charles Evan Ballantyne Other companies: Agenus Inc. (CFO · Jun 17, 2015 – Jun 14, 2016 · Past); Theriva Biologics, Inc. (Chief Financial Officer · Feb 6, 2012 – Jan 8, 2015 · Past); Clinical Data Inc (EVP, CFO · Jun 14, 2007 – Apr 12, 2011 · Past) | Chief Financial Officer · Apr 10, 2023 – Apr 10, 2023 · Past |
| Eric I Richman Other companies: NeuBase Therapeutics Inc (Director · Jul 12, 2019 – Sep 9, 2022 · Past); ADMA Biologics Inc (Director · Nov 9, 2017 – Feb 28, 2020 · Past) | Director · Since at least Mar 17, 2021 |
| Hans Peter Hasler Other companies: Minerva Neurosciences, Inc (Member · Since at least Dec 10, 2017); Patheon N.V. (Director · Jul 20, 2016 – Aug 29, 2017 · Past) | Director · Since at least Mar 17, 2021 |
| Gene Mack Other companies: SELLAS Life Sciences Group, Inc. (CFO and Treasurer · Apr 20, 2018 – Apr 20, 2018 · Past) | Chief Executive Officer · Since at least Apr 5, 2024 |
| Jeffrey Riley Other companies: Theriva Biologics, Inc. (Chief Executive Officer, Director · Mar 16, 2010 – Nov 30, 2016 · Past) | Independent Member · Since at least Mar 17, 2021 |
| Apaar Jammu | Director, Investor Relations and Public Relations · Since at least Oct 8, 2026 |
| Claude Nicaise | Independent Member · Since at least Nov 5, 2026 |
| Dov Goldstein | Independent Member · Since at least Nov 5, 2026 |
| Gianluca Fuggetta | See Remark · Since at least Dec 12, 2022 |
| Gwen Melincoff | Independent Member · Since at least Nov 5, 2026 |
| Investors:Gain Therapeutics | Inc. Apaar Jammu Director, Investor Relations and Public · Since at least Oct 1, 2026 |
| Khalid Islam | Chairman · Since at least Nov 5, 2026 |
| Manolo Bellotto | President and General Manager · Mar 17, 2021 – Mar 17, 2021 · Past |
| Salvatore Calabrese | Chief Financial Officer · Mar 17, 2021 – Mar 23, 2023 · Past |